This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topics apps close
search

Regulatory Affairs, Biotech & Pharma

Where regulatory meets e-regulatory: bringing answers to the pharmaceutical industry.

Articles & Video

Showing 22 of 38 articles & video
Featured

The Future of the Global Pharmaceutical Regulatory Affairs Industry

In a new interactive ebook, we take a deep dive into the challenges and trends we may see in pharmaceutical regulatory affairs over the next decade.
Premium
监管事务

Pharma and Medical Device Regulations Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the hottest topics in pharma, biotech and medical device regulatory affairs and law with one simple registration.
Regulatory Information Management

Is your Regulatory Information Management process putting your company at risk?

Many companies are putting themselves at risk lacking AI -powered RIM systems for regulatory data management. Get the details in this complimentary article.
MedTech eBook Series

Clinical Evaluations for Medical Devices and IVDs - MedTech eBook Series

Discover how the EU MDR will affect clinical evaluations for medical devices and IVDs in this MedTech Summit eBook.
监管事务

Post-event Report: Global Pharmaceutical Regulatory Affairs Summit 2020

This report takes a detailed look back at the 2020 virtual Global Pharmaceutical Regulatory Affairs Summit.
COVID-19

Report: Partnering And Deal-Making in Pharma through the Pandemic

This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
监管事务

What is standing in the way of global harmonisation?

Despite many efforts to globalise the pharmaceutical market, why are regulatory affairs still a challenge for drug manufacturers? Figen Kabadas highlights the obstacles.
Healthcare

REPORT: The Future of Healthcare Post COVID-19

In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Diversity and Inclusion

Women in Pharma: 44% of pharma professionals think that women are under represented in their organization

44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
ANVISA的

Regulations in Brazil: What the drug approval process is like in 2020

How has Brazil and LATAM adapted pharmaceutical regulations according to COVID-19 and harmonisation with other regions?
生物制药

SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic

We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
监管事务

Barriers and Challenges for Global Regulatory Harmonization

What obstacles are keeping regions such as Latin America from achieving regulatory harmonization with the rest of the world?
监管事务

Oligonucleotides and peptides: the regulatory challenges

We investigate where current regulatory obstacles lie surrounding peptide and oligonucleotide therapeutics.
ChinaBio Partnering Forum 2020

Top Biotech Deals in China

Discover the deals transforming China biotech! More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new free infographic.
Drug Development

Pharma R&D Annual Review 2020

The researchers and analysts at Pharma Intelligence have taken the guess work out of figuring out how pharmaceutical research and development has progressed over the past few years and what you can expect in 2020. Pharma R&D Annual Review 2020 condenses the thorough analysis of all drugs in development by pharmaceutical companies, from those at the preclinical stage, through the various stages of clinical testing and regulatory approval, and up to and including launch.
COVID-19

80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months

How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
MedTech eBook Series

The EU MDR Delay and Implementation - MedTech eBook Series

Discover the challenges of EU MDR implementation and impacts of the delay on the medical device industry in this MedTech eBook.
Life Sciences

The biggest breakthroughs in life sciences the last 10 years

CRISPR CAR-T,immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Brazil

Brazil & LATAM Pharmaceutical Regulations: Global Harmonisation & the Impact of Covid-19

We speak to two industry experts about how Brazil and LATAM region is working toward global regulatory harmonisation.
Premiumget_app
Diversity and Inclusion

Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER

本文着眼于如何促进种族,性别,geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
Diversity

REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020

Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Premium
IDMP

The Future of IDMP: Quick Fire Questions with the Experts

We spoke to five experts from across regulatory information management about IDMP, the impact of COVID-19 and common obstacles.

Copyright ©2020yabovip188